10.1007/s00198-018-4649-8 Summary Keywords glucagon-like peptide-1, diabetes mellitus, glucagon-like peptide 1 receptor agonists, osteoporosis, bone resorption Citation Xie B, Chen S, Xu Y, Han W, Hu R, Chen M, Zhang Y and Ding S (2021) The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
Of the patients with an HbA1c result at three months, 40% had an HbA1c lower than when they discontinued treatment, and another 48% kept at least some of their improvement
A glutathione precursor that supports respiratory health and liver function
Risk factors for B12 deficiency include strict vegetarian diets, gastrointestinal conditions, and certain medications
Robust, compelling evidence: In the Phase 3 ESSENCE trial (Part 1), 63% of patients receiving Wegovy achieved resolution of steatohepatitis without worsening fibrosis, compared with 34% on placebo
Learn why its becoming a preferred option for women with metabolic slowdowns or insulin resistance here: Explore Tirzepatide options